Arcus Graham Number from 2010 to 2024

RCUS Stock  USD 17.96  0.54  3.10%   
Arcus Biosciences Graham Number yearly trend continues to be comparatively stable with very little volatility. Graham Number will likely drop to 13.22 in 2024. From the period from 2010 to 2024, Arcus Biosciences Graham Number quarterly data regression had r-value of  0.76 and coefficient of variation of  49.59. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
24.14069198
Current Value
13.22
Quarterly Volatility
6.42919167
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 41 M, Interest Income of 43 M or Depreciation And Amortization of 6.1 M, as well as many indicators such as Price To Sales Ratio of 11.48, Dividend Yield of 0.0 or PTB Ratio of 3.39. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.
  
Check out the analysis of Arcus Biosciences Correlation against competitors.
For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Latest Arcus Biosciences' Graham Number Growth Pattern

Below is the plot of the Graham Number of Arcus Biosciences over the last few years. It is Arcus Biosciences' Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcus Biosciences' overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

Arcus Graham Number Regression Statistics

Arithmetic Mean12.96
Geometric Mean11.78
Coefficient Of Variation49.59
Mean Deviation4.98
Median10.07
Standard Deviation6.43
Sample Variance41.33
Range19.426
R-Value0.76
Mean Square Error18.74
R-Squared0.58
Significance0.001
Slope1.09
Total Sum of Squares578.68

Arcus Graham Number History

2024 13.22
2023 24.14
2022 27.59
2021 14.45
2020 20.96
2019 12.07
2018 14.79

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as Graham Number, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Graham Number 24.14  13.22 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.